Agonists and antagonists for excitatory amino acid receptors

Trends in Neurosciences - Tập 10 Số 7 - Trang 265-272 - 1987
J.C. Watkins1, Henry J. Olverman2
1Department of Pharmacology, The Medical School, University of Bristol, Bristol BS8 1TD, UK
2Department of Pharmacology, University of Edinburgh, 1 George Square, Edinburgh, EH8 9JZ, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Curtis, 1965, Pharmacol. Rev., 17, 347

Watkins, 1962, J. Med. Pharm. Chem., 5, 1187, 10.1021/jm01241a010

Watkins, 1986, 1

Evans, 1978, Brain Res., 148, 536, 10.1016/0006-8993(78)90744-8

Watkins, 1981, Annu. Rev. Pharmacol. Toxicol., 21, 165, 10.1146/annurev.pa.21.040181.001121

Fagg, 1986, Trends Pharmacol. Sci., 7, 357, 10.1016/0165-6147(86)90386-X

Mayer, 1986, Prog. Neurobiol., 28, 197, 10.1016/0301-0082(87)90011-6

McLennan, 1983, Prog. Neurobiol., 20, 251, 10.1016/0301-0082(83)90004-7

Foster, 1984, Brain Res. Rev., 7, 103, 10.1016/0165-0173(84)90020-1

Krogsgaard-Larsen, 1983, Trends Pharmacol. Sci., 4, 31, 10.1016/0165-6147(83)90272-9

Agrawal, 1986, Br. J. Pharmacol., 87, 345, 10.1111/j.1476-5381.1986.tb10823.x

Cotman, 1986, J. Physiol. (London), 378, 403, 10.1113/jphysiol.1986.sp016227

Davies, 1982, Brain. Res., 235, 378, 10.1016/0006-8993(82)91017-4

Davies, 1985, Brain Res., 327, 113, 10.1016/0006-8993(85)91505-7

Luini, 1981, 78, 3250

Miller, 1986, Trends Neurosci., 9, 211, 10.1016/0166-2236(86)90061-5

Watkins, 1978, 37

Watkins, 1980, Trends Neurosci., 3, 61

Evans, 1978, Eur. J. Pharmacol., 123, 10.1016/0014-2999(78)90007-9

Davies, 1986, Brain Res., 382, 169, 10.1016/0006-8993(86)90127-7

Olverman, 1984, Nature, 307, 460, 10.1038/307460a0

Olverman, 1986, Eur. J. Pharmacol., 131, 161, 10.1016/0014-2999(86)90533-9

Watkins, 1987, 19

Evans, 1979, Br. J. Pharmacol., 67, 591, 10.1111/j.1476-5381.1979.tb08706.x

Evans, 1982, Br. J. Pharmacol., 75, 65, 10.1111/j.1476-5381.1982.tb08758.x

London, 1979, Mol. Pharmacol., 15, 492

Honore, 1982, J. Neurochem., 38, 173, 10.1111/j.1471-4159.1982.tb10868.x

Davies, 1979, J. Physiol. (London), 298, 631

Krogsgaard-Larsen, 1980, Nature, 284, 64, 10.1038/284064a0

McLennan, 1979, Brain Res., 169, 83, 10.1016/0006-8993(79)90375-5

Davies, 1984, Neurosci. Lett., 52, 79, 10.1016/0304-3940(84)90354-9

Jones, 1984, Neuroscience, 13, 573, 10.1016/0306-4522(84)90250-1

Evans, 1977, Eur. J. Pharmacol., 44, 325, 10.1016/0014-2999(77)90306-5

Anis, 1983, Br. J. Pharmacol., 79, 565, 10.1111/j.1476-5381.1983.tb11031.x

Berry, 1984, Br. J. Pharmacol., 83, 179, 10.1111/j.1476-5381.1984.tb10133.x

Wong, 1986, 83, 7104

Davies, 1982, Neurochem. Res., 7, 1119, 10.1007/BF00964890

Wheatley, 1986, Eur. J. Pharmacol., 121, 257, 10.1016/0014-2999(86)90497-8

Martell, 1964, Chemical Society (London) Special Publication No. 17

Watkins, 1981, 1

Perkins, 1982, Brain Res., 247, 184, 10.1016/0006-8993(82)91048-4